SCHEMBL1502383

SCHEMBL1502383

COc1cc(N)ccc1C(=O)NCC1CNCCO1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.53
KDM4E B2RXH2 4/20 0.51
CHEK1 O14757 1/20 0.49
CRBN Q96SW2 1/20 0.44
HTR4 Q13639 1/20 0.44
ADRA2C P18825 1/20 0.44
ALDH1A1 P00352 5/20 0.43
POLB P06746 1/20 0.43
GAA P10253 2/20 0.42
CASP1 P29466 2/20 0.42
CASP7 P55210 2/20 0.42
HSD17B10 Q99714 2/20 0.42
KMT2A Q03164 6/20 0.42
MEN1 O00255 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
GLA P06280 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3633425 0.90 CHEK1 (0.48) HPGDKDM4ECHEK1ALDH1A1GAA
SCHEMBL1502385 0.83 KDM4E (0.52) HPGDKDM4ECHEK1HTR4ALDH1A1
SCHEMBL1501969 0.83 HTR4 (0.66) KDM4EHTR4ADRA2CALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL9021789 0.82 HTR4 (0.65) KDM4EHTR4
SCHEMBL7991765 0.78 HTR4 (0.64) KDM4EHTR4
SCHEMBL1501974 0.76 CHEK1 (0.44) HPGDKDM4ECHEK1ALDH1A1POLB
SCHEMBL1502177 0.76 CHEK1 (0.44) HPGDKDM4ECHEK1HTR4ALDH1A1
SCHEMBL13162864 0.75 CHEK1 (0.56) HPGDKDM4ECHEK1ALDH1A1HSD17B10
SCHEMBL1753594 0.74 MKNK2 (0.50) HPGDKDM4ECHEK1ADRA2CALDH1A1
SCHEMBL1502335 0.73 HTR1A (0.47) HPGDKDM4ECHEK1HTR4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256114-B1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAINIPPON SUMITOMO PHARMA CO (JP) 2014-06-25 EP disclosed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US disclosed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US disclosed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US disclosed
EP-2256114-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Dainippon Sumitomo Pharma Co., Ltd. (JP) 2010-12-01 EP disclosed
EP-2256114-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Dainippon Sumitomo Pharma Co., Ltd. (JP) 2010-12-01 EP disclosed
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Sumitomo Pharma Co., Ltd. (JP) 2010-09-30 US disclosed
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Sumitomo Pharma Co., Ltd. (JP) 2010-09-30 US disclosed
WO-2009104729-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 大日本住友製薬株式会社 (JP) 2009-08-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME HTR4, MC2R, HTR1D HPGD 1465/4885KDM4E 4027/4885CHEK1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.